phosphorodithioic acid has been researched along with oblimersen in 2 studies
Studies (phosphorodithioic acid) | Trials (phosphorodithioic acid) | Recent Studies (post-2010) (phosphorodithioic acid) | Studies (oblimersen) | Trials (oblimersen) | Recent Studies (post-2010) (oblimersen) |
---|---|---|---|---|---|
129 | 0 | 51 | 195 | 40 | 27 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benimetskaya, L; Colombini, M; Lai, JC; Miller, P; Stein, CA; Tan, W | 1 |
Amartey, J; Noe, CR; Stessl, M; Winkler, J | 1 |
2 other study(ies) available for phosphorodithioic acid and oblimersen
Article | Year |
---|---|
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.
Topics: Base Sequence; Cell Line, Tumor; Cytochromes c; Humans; Ion Channel Gating; Melanoma; Mitochondria; Mitochondrial Membranes; Oligonucleotides; Phosphates; Thionucleotides; Voltage-Dependent Anion Channels | 2006 |
Off-target effects related to the phosphorothioate modification of nucleic acids.
Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Humans; Intercellular Adhesion Molecule-1; Lactates; Melanoma; Oligonucleotides, Antisense; Phosphates; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Thionucleotides | 2010 |